 | • レポートコード：QYR9NV17594 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、副腎皮質がん薬の世界市場について調査・分析し、副腎皮質がん薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、標的療法）、用途別（病院、研究所、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の副腎皮質がん薬市場動向 ・主要企業別マーケットシェア ・副腎皮質がん薬の種類別市場規模2014-2019 （化学療法、標的療法） ・副腎皮質がん薬の用途別市場規模2014-2019 （病院、研究所、クリニック、その他） ・副腎皮質がん薬の北米市場：主要企業・種類別/用途別市場規模 ・副腎皮質がん薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・副腎皮質がん薬の中国市場：主要企業・種類別/用途別市場規模 ・副腎皮質がん薬の日本国内市場：主要企業・種類別/用途別市場規模 ・副腎皮質がん薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・副腎皮質がん薬のインド市場：主要企業・種類別/用途別市場規模 ・副腎皮質がん薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Bristol-Myers Squibb Co.、Eli Lilly and Co.、Laboratoire HRA Pharma SAS、Progenics Pharmaceuticals Inc.、Teva Pharmaceutical Industries Ltd.） ・副腎皮質がん薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
The adrenocortical carcinoma drugs market has recorded the development of several advanced imaging techniques, which are non-invasive and exhibit enhanced diagnostic accuracy in the detection of adrenal lesions.For instance, unenhanced computed tomography adrenal densitometry is used to differentiate adrenal adenomas from malignant lesions based on the presence of intracellular lipids. A combination of positron emission tomography/computed tomography is also gaining popularity among end-users for the identification of malignant and benign lesions. Similarly, multiphase computed tomography technique is being used to calculate absolute and relative percentage washout, and thereby, differentiate between benign and malignant lesions.
In 2018, the global Adrenocortical Carcinoma Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Adrenocortical Carcinoma Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adrenocortical Carcinoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Bristol-Myers Squibb Co.
Eli Lilly and Co.
Laboratoire HRA Pharma SAS
Progenics Pharmaceuticals Inc.
Teva Pharmaceutical Industries Ltd.
…
Market segment by Type, the product can be split into
Chemotherapy
Targeted therapy
Market segment by Application, split into
Hospital
Research institute
Clinic
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Adrenocortical Carcinoma Drugs status, future forecast, growth opportunity, key market and key players.
To present the Adrenocortical Carcinoma Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Adrenocortical Carcinoma Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Adrenocortical Carcinoma Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Targeted therapy
1.5 Market by Application
1.5.1 Global Adrenocortical Carcinoma Drugs Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Research institute
1.5.4 Clinic
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Adrenocortical Carcinoma Drugs Market Size
2.2 Adrenocortical Carcinoma Drugs Growth Trends by Regions
2.2.1 Adrenocortical Carcinoma Drugs Market Size by Regions (2019-2025)
2.2.2 Adrenocortical Carcinoma Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Adrenocortical Carcinoma Drugs Market Size by by Players
3.1.1 Global Adrenocortical Carcinoma Drugs Revenue by by Players (2014-2019)
3.1.2 Global Adrenocortical Carcinoma Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Adrenocortical Carcinoma Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Adrenocortical Carcinoma Drugs Key Players Head office and Area Served
3.3 Key Players Adrenocortical Carcinoma Drugs Product/Solution/Service
3.4 Date of Enter into Adrenocortical Carcinoma Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Adrenocortical Carcinoma Drugs Market Size by Type (2014-2019)
4.2 Global Adrenocortical Carcinoma Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Adrenocortical Carcinoma Drugs Market Size (2014-2019)
5.2 Adrenocortical Carcinoma Drugs Key Players in North America
5.3 North America Adrenocortical Carcinoma Drugs Market Size by Type
5.4 North America Adrenocortical Carcinoma Drugs Market Size by Application
6 Europe
6.1 Europe Adrenocortical Carcinoma Drugs Market Size (2014-2019)
6.2 Adrenocortical Carcinoma Drugs Key Players in Europe
6.3 Europe Adrenocortical Carcinoma Drugs Market Size by Type
6.4 Europe Adrenocortical Carcinoma Drugs Market Size by Application
7 China
7.1 China Adrenocortical Carcinoma Drugs Market Size (2014-2019)
7.2 Adrenocortical Carcinoma Drugs Key Players in China
7.3 China Adrenocortical Carcinoma Drugs Market Size by Type
7.4 China Adrenocortical Carcinoma Drugs Market Size by Application
8 Japan
8.1 Japan Adrenocortical Carcinoma Drugs Market Size (2014-2019)
8.2 Adrenocortical Carcinoma Drugs Key Players in Japan
8.3 Japan Adrenocortical Carcinoma Drugs Market Size by Type
8.4 Japan Adrenocortical Carcinoma Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Adrenocortical Carcinoma Drugs Market Size (2014-2019)
9.2 Adrenocortical Carcinoma Drugs Key Players in Southeast Asia
9.3 Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Type
9.4 Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Application
10 India
10.1 India Adrenocortical Carcinoma Drugs Market Size (2014-2019)
10.2 Adrenocortical Carcinoma Drugs Key Players in India
10.3 India Adrenocortical Carcinoma Drugs Market Size by Type
10.4 India Adrenocortical Carcinoma Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Adrenocortical Carcinoma Drugs Market Size (2014-2019)
11.2 Adrenocortical Carcinoma Drugs Key Players in Central & South America
11.3 Central & South America Adrenocortical Carcinoma Drugs Market Size by Type
11.4 Central & South America Adrenocortical Carcinoma Drugs Market Size by Application
12 International Players Profiles
12.1 Bristol-Myers Squibb Co.
12.1.1 Bristol-Myers Squibb Co. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Adrenocortical Carcinoma Drugs Introduction
12.1.4 Bristol-Myers Squibb Co. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019))
12.1.5 Bristol-Myers Squibb Co. Recent Development
12.2 Eli Lilly and Co.
12.2.1 Eli Lilly and Co. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Adrenocortical Carcinoma Drugs Introduction
12.2.4 Eli Lilly and Co. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
12.2.5 Eli Lilly and Co. Recent Development
12.3 Laboratoire HRA Pharma SAS
12.3.1 Laboratoire HRA Pharma SAS Company Details
12.3.2 Company Description and Business Overview
12.3.3 Adrenocortical Carcinoma Drugs Introduction
12.3.4 Laboratoire HRA Pharma SAS Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
12.3.5 Laboratoire HRA Pharma SAS Recent Development
12.4 Progenics Pharmaceuticals Inc.
12.4.1 Progenics Pharmaceuticals Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Adrenocortical Carcinoma Drugs Introduction
12.4.4 Progenics Pharmaceuticals Inc. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
12.4.5 Progenics Pharmaceuticals Inc. Recent Development
12.5 Teva Pharmaceutical Industries Ltd.
12.5.1 Teva Pharmaceutical Industries Ltd. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Adrenocortical Carcinoma Drugs Introduction
12.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Adrenocortical Carcinoma Drugs Business (2014-2019)
12.5.5 Teva Pharmaceutical Industries Ltd. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Adrenocortical Carcinoma Drugs Key Market Segments
Table Key Players Adrenocortical Carcinoma Drugs Covered
Table Global Adrenocortical Carcinoma Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Chemotherapy Figures
Table Key Players of Chemotherapy
Figuer Targeted therapy Figures
Table Key Players of Targeted therapy
Table Global Adrenocortical Carcinoma Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Adrenocortical Carcinoma Drugs Market Share by Application in 2018 & 2025
Figure Hospital Case Studies
Figure Research institute Case Studies
Figure Clinic Case Studies
Figure Other Case Studies
Figure Adrenocortical Carcinoma Drugs Report Years Considered
Figure Global Adrenocortical Carcinoma Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Adrenocortical Carcinoma Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Adrenocortical Carcinoma Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Adrenocortical Carcinoma Drugs Market Share by Regions 2014-2019
Figure Global Adrenocortical Carcinoma Drugs Market Share by Regions 2014-2019
Figure Global Adrenocortical Carcinoma Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Adrenocortical Carcinoma Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Adrenocortical Carcinoma Drugs Market Share by by Players (2014-2019)
Figure Global Adrenocortical Carcinoma Drugs Market Share by by Players in 2018
Table Global Adrenocortical Carcinoma Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Adrenocortical Carcinoma Drugs Product/Solution/Service
Table Date of Enter into Adrenocortical Carcinoma Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Adrenocortical Carcinoma Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Adrenocortical Carcinoma Drugs Market Size Share by Type (2014-2019)
Figure Global Adrenocortical Carcinoma Drugs Market Size Market Share by Type (2014-2019)
Table Global Adrenocortical Carcinoma Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Adrenocortical Carcinoma Drugs Market Size Share by Application (2014-2019)
Figure Global Adrenocortical Carcinoma Drugs Market Size Market Share by Application (2014-2019)
Figure Global Adrenocortical Carcinoma Drugs Revenue Market Share by Application in 2018
Figure North America Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019)
Table North America Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019
Table North America Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019
Figure Europe Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019)
Table Europe Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019
Table Europe Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019
Figure China Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019)
Table China Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$)
Table China Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019
Table China Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$)
Table China Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019
Figure Japan Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019)
Table Japan Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019
Table Japan Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019
Figure Southeast Asia Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019)
Table Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019
Table Southeast Asia Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019
Figure India Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019)
Table India Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$)
Table India Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019
Table India Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$)
Table India Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019
Figure Central & South America Adrenocortical Carcinoma Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Adrenocortical Carcinoma Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Adrenocortical Carcinoma Drugs Market Share (2018-2019)
Table Central & South America Adrenocortical Carcinoma Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Adrenocortical Carcinoma Drugs Market Share by Type 2014-2019
Table Central & South America Adrenocortical Carcinoma Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Adrenocortical Carcinoma Drugs Market Share by Application 2014-2019
Table Bristol-Myers Squibb Co. Company Details
Table Bristol-Myers Squibb Co. Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$)
Figure Bristol-Myers Squibb Co. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019)
Table Bristol-Myers Squibb Co. Recent Development
Table Eli Lilly and Co. Company Details
Table Eli Lilly and Co. Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$)
Figure Eli Lilly and Co. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019)
Table Eli Lilly and Co. Recent Development
Table Laboratoire HRA Pharma SAS Company Details
Table Laboratoire HRA Pharma SAS Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$)
Figure Laboratoire HRA Pharma SAS Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019)
Table Laboratoire HRA Pharma SAS Recent Development
Table Progenics Pharmaceuticals Inc. Company Details
Table Progenics Pharmaceuticals Inc. Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$)
Figure Progenics Pharmaceuticals Inc. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019)
Table Progenics Pharmaceuticals Inc. Recent Development
Table Teva Pharmaceutical Industries Ltd. Company Details
Table Teva Pharmaceutical Industries Ltd. Revenue in Adrenocortical Carcinoma Drugs Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Adrenocortical Carcinoma Drugs Business (2014-2019)
Table Teva Pharmaceutical Industries Ltd. Recent Development
Table Global Adrenocortical Carcinoma Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Adrenocortical Carcinoma Drugs Market Size Share by Regions (2019-2025)
Figure Global Adrenocortical Carcinoma Drugs Market Size Share by Regions in 2025
Figure North America Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Adrenocortical Carcinoma Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Adrenocortical Carcinoma Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Adrenocortical Carcinoma Drugs Market Size by Product (2019-2025)
Figure Global Adrenocortical Carcinoma Drugs Market Size by Product in 2025
Table Global Adrenocortical Carcinoma Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Adrenocortical Carcinoma Drugs Market Size by Application (2019-2025)
Figure Global Adrenocortical Carcinoma Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
副腎皮質がん薬のグローバル市場：規模・現状・予測2019-2025 The adrenocortical carcinoma drugs market has recorded the development of several advanced imaging techniques, which are non-invasive and exhibit enhanced diagnostic accuracy in the detection of adrenal lesions.For instance, unenhanced computed tomography adrenal densitometry is used to differentiat…- 腎細胞がん治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Renal cell carcinoma (RCC) is a kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport primary urine. RCC is the most common type of kidney cancer in adults, responsible for approximately 90–95% of cases.The drug is …
- 非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…
- 非小細胞肺がん薬のグローバル市場：規模・現状・予測2019-2025 Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.The strong drug pipeline and drug approvals are one of the critical factors that will trigger the non-small cell lung cancer drugs…
- 食道癌治療薬のグローバル市場：規模・現状・予測2019-2025 Esophageal cancer is cancer arising from the esophagus—the food pipe that runs between the throat and the stomach.Symptoms often include difficulty in swallowing and weight loss.Other symptoms may include pain when swallowing, a hoarse voice, enlarged lymph nodes ("glands") around the collarbone, a …